A pilot program in Utah that would have allowed thousands of patients to consume psychedelic mushrooms for therapeutic use failed to advance in the state Senate on Wednesday, effectively ending its chances of passage as lawmakers prepare to adjourn for the year next week.
The Senate's health and human services committee neither advanced nor rejected the measure, with Republican leaders proposing more time to examine the issue.
